Plains GP Holdings, L.P. (PAGP)
| Market Cap | 6.27B +83.7% |
| Revenue (ttm) | 52.31B +12.2% |
| Net Income | 554.00M +307.4% |
| EPS | 1.59 +130.2% |
| Shares Out | 233.00M |
| PE Ratio | 16.99 |
| Forward PE | 16.41 |
| Dividend | $1.67 (6.20%) |
| Ex-Dividend Date | Oct 30, 2026 |
| Volume | 2,996,711 |
| Open | 27.41 |
| Previous Close | 27.61 |
| Day's Range | 26.73 - 27.42 |
| 52-Week Range | 16.89 - 28.96 |
| Beta | 0.51 |
| Analysts | Buy |
| Price Target | 26.77 (-0.59%) |
| Earnings Date | Nov 6, 2026 |
About PAGP
Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates through Crude Oil and Natural Gas Liquids (NGLs) segments. The company engages in the gathering and transporting crude oil using pipelines, trucks, and barges or railcars. It also provides terminalling, storage, and other related services. In addition, the company is involved in the natural gas processing and NGL fractionation, storage, transportation, and terminall... [Read more]
Financial Performance
In 2025, Plains GP Holdings's revenue was $44.26 billion, a decrease of -9.46% compared to the previous year's $48.89 billion. Earnings were $260.00 million, an increase of 152.43%.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for PAGP stock is "Buy." The 12-month stock price target is $26.77, which is a decrease of -0.59% from the latest price.
News
Plains GP Holdings price target raised to $30 from $29 at Raymond James
Raymond James analyst Justin Jenkins raised the firm’s price target on Plains GP Holdings (PAGP) to $30 from $29 and keeps a Strong Buy rating on the shares. Published first…
Plains GP Holdings price target raised to $30 from $26 at UBS
UBS raised the firm’s price target on Plains GP Holdings (PAGP) to $30 from $26 and keeps a Buy rating on the shares.
Plains All American Pipeline and Plains GP Holdings Announce Quarterly Distributions and Timing of Third Quarter 2026 Earnings
HOUSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) announced today their quarterly distributions with respect to the thir...
Plains appoints Dean Liollio as COO
Plains All American Pipeline (PAA) and Plains GP Holdings (PAGP) announced that Dean Liollio has been appointed to serve as executive VP and COO of Plains effective as of October…
Plains GP Holdings price target raised to $30 from $27 at Mizuho
Mizuho analyst Gabriel Moreen raised the firm’s price target on Plains GP Holdings (PAGP) to $30 from $27 and keeps an Outperform rating on the shares. The firm updated the…
Plains GP Holdings price target raised to $24 from $23 at Barclays
Barclays raised the firm’s price target on Plains GP Holdings (PAGP) to $24 from $23 and keeps an Underweight rating on the shares. The firm updated estimates in the midstream…
Plains GP Holdings price target raised to $27 from $23 at Citi
Citi raised the firm’s price target on Plains GP Holdings (PAGP) to $27 from $23 and keeps a Neutral rating on the shares. The firm cites Plain’s Silver Creek Midstream…
Plains GP Holdings resumed with a Buy at Stifel
Stifel analyst Robert Hodges resumed coverage of Plains GP Holdings (PAGP) with a Buy rating and $28 price target The firm feels that Plains “now offers investors a pure play,…
Plains GP Holdings price target raised to $27 from $24 at JPMorgan
JPMorgan raised the firm’s price target on Plains GP Holdings (PAGP) to $27 from $24 and keeps a Neutral rating on the shares. The firm updated the company’s model post…
Plains GP Holdings price target raised to $28 from $26 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Plains GP Holdings (PAGP) to $28 from $26 and keeps an Equal Weight rating on the shares.
Plains GP Holdings Slides: Investor presentation
Plains GP Holdings has posted slides in relation to its latest quarterly earnings report, which was published on August 9, 2026.
Plains GP Holdings Earnings Call Transcript: Q2 2026
Q2 adjusted EBITDA reached $738 million, supporting full-year guidance of $2.88 billion. Growth capital for 2026 was raised to $400–$450 million, with Permian and Canadian expansions driving future momentum. Leverage improved to 3.3x after the NGL sale.
Plains GP Holdings Earnings release: Q2 2026
Plains GP Holdings released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
Plains GP Holdings Slides: Q2 2026
Plains GP Holdings has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 7, 2026.
Plains GP Holdings Quarterly report: Q2 2026
Plains GP Holdings has published its Q2 2026 quarterly earnings report on August 7, 2026.
Plains GP Holdings price target raised to $23 from $21 at Barclays
Barclays analyst Theresa Chen raised the firm’s price target on Plains GP Holdings (PAGP) to $23 from $21 and keeps an Underweight rating on the shares. The firm adjusted the…
Plains raises FY26 capital spending view to $400M-$450M from $350M
Plains All American (PAA) and Plains GP Holdings (PAGP) are providing an update to capital spending guidance for 2026. Plains expects growth capital spending to increase from approximately $350M to…
Plains All American Pipeline and Plains GP Holdings Provide Updated Capital Spending Guidance for 2026
HOUSTON, June 15, 2026 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) (collectively, “Plains”) are providing an update to capital spending g...
Plains GP Holdings price target raised to $27 from $25 at Mizuho
Mizuho raised the firm’s price target on Plains GP Holdings (PAGP) to $27 from $25 and keeps an Outperform rating on the shares. The firm upped the company’s estimates to…
Plains GP Holdings upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst John Mackay upgraded Plains GP Holdings (PAGP) to Neutral from Sell with a price target of $24, up from $18. The firm cites the stronger crude price…
Plains GP Holdings price target raised to $26 from $24 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Plains GP Holdings (PAGP) to $26 from $24 and keeps an Equal Weight rating on the shares.
Plains GP Holdings price target raised to $23 from $20 at Citi
Citi raised the firm’s price target on Plains GP Holdings (PAGP) to $23 from $20 and keeps a Neutral rating on the shares. The firm cites increased cash flow estimates…
Plains GP Holdings Proxy statement: Proxy filing
Plains GP Holdings filed a proxy statement on May 13, 2026, providing details for shareholder voting and corporate governance matters.
Plains All American, Plains GP complete Canadian NGL divestiture
Plains All American Pipeline (PAA) and Plains GP Holdings (PAGP) completed the previously announced sale of all of the issued and outstanding shares of Plains Midstream Canada ULC, the PAA…
Plains GP Holdings Proxy statement: Proxy filing
Plains GP Holdings filed a proxy statement on May 11, 2026, providing details for shareholder voting and corporate governance matters.